BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11303038)

  • 1. Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice.
    Gaou I; Malliti M; Guimont MC; Lettéron P; Demeilliers C; Peytavin G; Degott C; Pessayre D; Fromenty B
    J Pharmacol Exp Ther; 2001 May; 297(2):516-23. PubMed ID: 11303038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
    Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
    Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute ethanol administration oxidatively damages and depletes mitochondrial dna in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants.
    Mansouri A; Demeilliers C; Amsellem S; Pessayre D; Fromenty B
    J Pharmacol Exp Ther; 2001 Aug; 298(2):737-43. PubMed ID: 11454938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
    Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
    Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine.
    Velsor LW; Kovacevic M; Goldstein M; Leitner HM; Lewis W; Day BJ
    Toxicol Appl Pharmacol; 2004 Aug; 199(1):10-9. PubMed ID: 15289086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
    Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
    J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged ethanol administration depletes mitochondrial DNA in MnSOD-overexpressing transgenic mice, but not in their wild type littermates.
    Larosche I; Choumar A; Fromenty B; Lettéron P; Abbey-Toby A; Van Remmen H; Epstein CJ; Richardson A; Feldmann G; Pessayre D; Mansouri A
    Toxicol Appl Pharmacol; 2009 Feb; 234(3):326-38. PubMed ID: 19063909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic stavudine exposure induces hepatic mitochondrial toxicity in adult Erythrocebus patas monkeys.
    Gerschenson M; Nguyen VT; St Claire MC; Harbaugh SW; Harbaugh JW; Proia LA; Poirier MC
    J Hum Virol; 2001; 4(6):335-42. PubMed ID: 12082400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
    Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
    J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
    Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting.
    Maisonneuve C; Igoudjil A; Begriche K; Lettéron P; Guimont MC; Bastin J; Laigneau JP; Pessayre D; Fromenty B
    Antivir Ther; 2004 Oct; 9(5):801-10. PubMed ID: 15535418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver.
    Larosche I; Lettéron P; Fromenty B; Vadrot N; Abbey-Toby A; Feldmann G; Pessayre D; Mansouri A
    J Pharmacol Exp Ther; 2007 May; 321(2):526-35. PubMed ID: 17277197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketone body metabolism in lean and obese women.
    Vice E; Privette JD; Hickner RC; Barakat HA
    Metabolism; 2005 Nov; 54(11):1542-5. PubMed ID: 16253646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.
    Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P
    J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
    Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice.
    Igoudjil A; Abbey-Toby A; Begriche K; Grodet A; Chataigner K; Peytavin G; Maachi M; Colin M; Robin MA; Lettéron P; Feldmann G; Pessayre D; Fromenty B
    Antivir Ther; 2007; 12(3):389-400. PubMed ID: 17591029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.
    Mallon PW; Unemori P; Sedwell R; Morey A; Rafferty M; Williams K; Chisholm D; Samaras K; Emery S; Kelleher A; Cooper DA; Carr A;
    J Infect Dis; 2005 May; 191(10):1686-96. PubMed ID: 15838796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.